Boss of tiny Oxford firm is 'extremely optimistic' over one-a-day pill it has developed to combat coronavirus

  • BerGenBio, a British-Norwegian company has just 38 staff working for them
  • The firm believe they have found the key to combat the coronavirus
  • Chief executive of the company said tests on SARS-Cov-2 'showed big effects'
  • It works by stopping the virus from utilising a naturally occurring protein, AXL
  • The small firm is competing with pharmaceutical giants to find a treatment

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here